¼¼°èÀÇ ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå
Ambulatory Cardiac Monitoring Devices
»óǰÄÚµå : 1784968
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 287 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,150,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,452,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2030³â±îÁö 123¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 68¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 10.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 123¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ECG ±â±â´Â CAGR 11.3%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 64¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ȦÅÍ ¸ð´ÏÅÍ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 10.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 19¾ï ´Þ·¯, Áß±¹Àº CAGR14.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2024³â¿¡ 19¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR14.1%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿©, 2030³â¿¡´Â 25¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 7.3%¿Í 9.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 8.1%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â°¡ Çö´ë ÀÇ·á¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â´Â Çö´ë ½ÉÇ÷°ü °Ç°­ °ü¸®ÀÇ ÇÙ½ÉÀ¸·Î, ±âÁ¸ÀÇ ÀÓ»ó ȯ°æ ¹Û¿¡¼­µµ ½ÉÀå Ȱµ¿À» Áö¼ÓÀûÀ¸·Î ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ´Ü±âÀûÀÎ ÀÓ»ó Æò°¡·Î´Â °¨ÁöÇÒ ¼ö ¾ø´Â ºÎÁ¤¸Æ, ½É¹æ¼¼µ¿ ¹× ±âŸ ½ÉÀå Áúȯ¿¡ ´ëÇÑ Áß¿äÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÁÂ½Ä »ýȰ½À°ü, ºñ¸¸À² Áõ°¡, °í·ÉÈ­·Î ÀÎÇÑ ½ÉÇ÷°ü Áúȯ(CVDs) À¯º´·ü Áõ°¡´Â ¿Ü·¡ ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ¿Í ÀÇ·áÁøÀº ºÒ±ÔÄ¢ÇÑ ½ÉÀå ¸®µëÀ» Àå±â°£¿¡ °ÉÃÄ °¨ÁöÇÏ¿© Àû½Ã¿¡ Áø´ÜÇÏ°í °³ÀÔÇÒ ¼ö ÀÖµµ·Ï Çϱâ À§ÇØ ÀÌ·¯ÇÑ ±â±â¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â´Â Ä¡·á ÈÄ È¯ÀÚÀÇ Àå±â ÃßÀûÀ» ¿ëÀÌÇϰÔÇÏ°í ¸¸¼º ½ÉÀå ÁúȯÀÇ ´õ ³ªÀº °ü¸®¸¦ º¸ÀåÇÏ¸ç ½ÉÀå ÁúȯÀÇ Àç¹ß À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

ÀçÅÃÄ¡·á·ÎÀÇ Àüȯ°ú ¿¹¹æ ÀÇÇп¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±âÀÇ Ã¤ÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ȯÀÚµéÀº Æí¸®ÇÔ, Æí¾ÈÇÔ, ÀæÀº ¹æ¹® ¾øÀ̵µ Á¤È®ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÒ ¼ö ÀÖ´Â ´É·Â ¶§¹®¿¡ ÀÌ·¯ÇÑ ±â±â¸¦ ¼±È£ÇÕ´Ï´Ù. ÇÑÆí, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ȯÀÚ °ü¸®¸¦ ÃÖÀûÈ­Çϰí, º´¿ø ÀçÀÔ¿øÀ» ÁÙÀ̰í, ÀÚ¿øÀ» º¸´Ù È¿À²ÀûÀ¸·Î ¹èºÐÇϱâ À§ÇØ ÀÌ·¯ÇÑ Àåºñ¸¦ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ÀÇ·á ½Ã½ºÅÛ¿¡ ´ëÇÑ ºÎ´ãÀÌ Áõ°¡ÇÏ´Â °¡¿îµ¥, ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀÇ·á ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ´Â ±ÍÁßÇÑ µµ±¸·Î ÀÔÁõµÇ°í ÀÖ½À´Ï´Ù. AI ±â¹Ý ºÐ¼® ¹× ½Ç½Ã°£ ¿ø°Ý ¸ð´ÏÅ͸µ°ú °°Àº ÷´Ü ±â¼úÀÇ ÅëÇÕÀ¸·Î ÀÌ·¯ÇÑ ±â±âÀÇ »ç¿ë ÆíÀǼº°ú È¿À²¼ºÀÌ ´õ¿í Çâ»óµÇ¾î Çö´ë ÀÇ·á ȯ°æ¿¡¼­ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â¸¦ ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ÀÌ·¯ÇÑ ±â±âÀÇ Á¤È®¼º, È޴뼺, ±â´É¼ºÀ» Çâ»ó½ÃÅ´À¸·Î½á ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ºÐ¾ß¿¡ Çõ¸íÀ» ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÷´Ü ¹ÙÀÌ¿À¼¾¼­¸¦ žÀçÇÑ ¿þ¾î·¯ºí ±â±âÀÇ °³¹ß·Î ½É¹Ú¼ö, ¸®µë, Àü±âÀû Ȱµ¿°ú °°Àº Áß¿äÇÑ ½ÉÀå ¸Å°³º¯¼ö¸¦ Áö¼ÓÀûÀ¸·Î ºñħ½ÀÀûÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ºí·çÅõ½º ¹× Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû°ú °°Àº ¹«¼± ¿¬°á ±â´ÉÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô ¿øÈ°ÇÑ µ¥ÀÌÅÍ Àü¼ÛÀÌ °¡´ÉÇÏ¿© ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× ¿ø°Ý Áø·á°¡ ¿ëÀÌÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ¿¬°á¼ºÀº ȯÀÚÀÇ ¼øÀÀµµ¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, ½ÉÀå ÀÌ»ó ¹ß»ý ½Ã Àû½Ã¿¡ ÀÇ·áÀû °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, ÀΰøÁö´É°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» ¸ð´ÏÅ͸µ ±â±â¿¡ ÅëÇÕÇÏ¿© µ¥ÀÌÅÍ ºÐ¼®À» Å©°Ô °³¼±ÇÏ¿© ½ÉÀå ÀÌ»óÀ» º¸´Ù Á¤È®ÇÏ°Ô Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¼ÒÇüÈ­¿Í ÀÎü°øÇÐÀû µðÀÚÀεµ ȯÀÚÀÇ Æí¾ÈÇÔ°ú ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ±âÁ¸ÀÇ ºÎÇǰ¡ Å« ȦÅÍ ¸ð´ÏÅʹ ȯÀÚ°¡ ºÒÆíÇÔ ¾øÀÌ ÀÏ»ó»ýȰÀ» ÇÒ ¼ö ÀÖ´Â °¡º±°í ´«¿¡ Àß ¶çÁö ¾Ê´Â ¿þ¾î·¯ºí ±â±â·Î ´ëüµÇ°í ÀÖ½À´Ï´Ù. À̺¥Æ® ¸ð´ÏÅͳª ÆÐÄ¡Çü ECG ¸ð´ÏÅÍ¿Í °°Àº ÀåÄ¡´Â »ç¿ëÀÇ Æí¸®ÇÔ°ú Âø¿ë ½Ã°£ÀÇ ±æÀÌ·Î ÀÎÇØ ȯÀÚµéÀÇ È£ÀÀÀ» ¾òÀ¸¸ç Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹èÅ͸® ±â¼úÀÇ ¹ßÀüÀ¸·Î ´õ ¿À·£ ½Ã°£ ¸ð´ÏÅ͸µÀÌ °¡´ÉÇØÁ® ÀæÀº ±â±â ±³Ã¼ ¹× ÃæÀüÀÇ Çʿ伺ÀÌ ÁÙ¾îµé°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â¿Í µ¿±âÈ­µÇ´Â ½º¸¶Æ®Æù ¿ëµµ¸¦ ÅëÇÕÇÏ¿© Áï°¢ÀûÀÎ Çǵå¹é°ú °æ°í¸¦ Á¦°øÇϰí, Àû±ØÀûÀÎ °Ç°­ °ü¸®¸¦ ÃËÁøÇÔÀ¸·Î½á ȯÀÚÀÇ ½ÉÀå °Ç°­ °ü¸® ´É·ÂÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ »õ·Î¿î µ¿ÇâÀº?

¿Ü·¡ ȯÀÚµéÀÇ ±â´ëÄ¡¿Í ±â¼ú Çõ½Å¿¡ µû¶ó ¿Ü·¡ ȯÀÚ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¹Ì·¡´Â ¸î °¡Áö »õ·Î¿î Æ®·»µå°¡ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â ƯÈ÷ Äڷγª19 ÆÒµ¥¹ÍÀ» °è±â·Î Áö¼ÓÀûÀÎ ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ¿ø°Ý ÀÇ·á ¼­ºñ½º µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ȯÀÚ¸¦ ¿ø°ÝÀ¸·Î ÃßÀûÇϰí Á÷Á¢ ¹æ¹®ÇÏÁö ¾Ê°íµµ Àû½Ã¿¡ ÀÇ·á °³ÀÔÀ» º¸ÀåÇϱâ À§ÇØ ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸¦ µµÀÔÇÏ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ƯÈ÷ °íÀ§Ç豺 ½ÉÀ庴 ȯÀÚ °ü¸®¿¡¼­ µÎµå·¯Áö¸ç, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀº »ý¸íÀ» À§ÇùÇÏ´Â »ç°ÇÀ» ¿¹¹æÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ Æ®·»µå´Â ½ÉÀå ¸ð´ÏÅ͸µ ±â´ÉÀÌ ³»ÀåµÈ ¿þ¾î·¯ºí ÇÇÆ®´Ï½º ±â±âÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϸ鼭 ½ÉÀå ºÎÁ¤¸ÆÀ» Á¶±â¿¡ ¹ß°ßÇÏ´Â µ¥ Ȱ¿ëµÇ´Â »ç·Ê°¡ ´Ã°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ½ÉÀå °Ç°­¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¿þ¾î·¯ºí °Ç°­ ±â¼úÀº ´õ¿í Á¤±³ÇÑ ¸ð´ÏÅ͸µ ±â´ÉÀ» Á¦°øÇϵµ·Ï ÁøÈ­Çϰí ÀÖÀ¸¸ç, ÀÇ·á¿ë ±â±â¿Í ¼ÒºñÀÚ °¡ÀüÁ¦Ç°ÀÇ °æ°è°¡ ¸ðÈ£ÇØÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ŭ¶ó¿ìµå ±â¹Ý ºÐ¼® Ç÷§ÆûÀÇ °³¹ß·Î ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ´ë±Ô¸ð ȯÀÚ µ¥ÀÌÅÍ¿¡ Á¢±ÙÇÏ¿© Ãß¼¼¸¦ ÆÄ¾ÇÇϰí, Çö½Ç ¼¼°èÀÇ ÅëÂû·ÂÀ» ¹ÙÅÁÀ¸·Î °³ÀÎÈ­µÈ Ä¡·á °èȹÀ» ¼ö¸³ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ȯÀÚ Áß½É Ä¡·á¿Í Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀº ȯÀÚ °³°³ÀÎÀÇ Æ¯Á¤ ¿ä±¸¿¡ ´ëÀÀÇÏ°í ¸ÂÃãÇü ÅëÂû·Â°ú ÃßõÀ» Á¦°øÇÏ´Â ¸ÂÃãÇü ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

¿Ü·¡ ȯÀÚ ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ½ÉÇ÷°ü Áúȯ ¹ßº´·ü Áõ°¡, ¿þ¾î·¯ºí °Ç°­ ±â¼úÀÇ ¹ßÀü, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. IoT Áö¿ø ÀåÄ¡¿Í AI¸¦ Ȱ¿ëÇÑ ºÐ¼®ÀÇ º¸±ÞÀ¸·Î ¿øÈ°ÇÑ µ¥ÀÌÅÍ ¼öÁý°ú ÇØ¼®ÀÌ ¿ëÀÌÇØÁ® ¿Ü·¡ ȯÀÚ ¸ð´ÏÅ͸µÀÇ È¿À²¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. Àû±ØÀûÀÎ °Ç°­ °ü¸®·Î ¼ÒºñÀÚ ÇൿÀÌ º¯È­ÇÔ¿¡ µû¶ó ȯÀÚ°¡ ½ÉÀå °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ´Â »ç¿ëÇϱ⠽±°í ºñħ½ÀÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÅà Áø·á ¹× ¿Ü·¡ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀº ÀÔ¿øÀ» ÁÙÀ̰í ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ´Â ºñ¿ë È¿À²ÀûÀÎ ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ Ç÷§Æû°ú ¿ø°Ý ÀÇ·á ¼­ºñ½ºÀÇ µµÀÔÀÌ Áõ°¡Çϸ鼭 ´õ ³ªÀº ÀÓ»óÀû ÀÇ»ç°áÁ¤À» À§ÇØ ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°ú ¸ð´ÏÅ͸µ µ¥ÀÌÅ͸¦ ¿øÈ°ÇÏ°Ô ÅëÇÕÇÒ ¼ö ÀÖ°Ô µÈ °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¹æ ÀǷḦ Àå·ÁÇϰí ÀÇ·áºñ Àý°¨À» À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í »óȯ Á¤Ã¥Àº Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ¿Ü·¡ ½ÉÀå ¸ð´ÏÅ͸µ ±â±âÀÇ º¸±ÞÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

µð¹ÙÀ̽º(ECG µð¹ÙÀ̽º, ȦÅÍ ¸ð´ÏÅÍ, À̺¥Æ® ¸ð´ÏÅÍ, ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® µð¹ÙÀ̽º, »ðÀÔÇü ·çÇÁ ¸®ÄÚ´õ);ÃÖÁ¾ »ç¿ë(º´¿ø ¹× Áø·á¼Ò, ¿Ü·¡ ÄÉ¾î ¼¾ÅÍ, ±âŸ ÃÖÁ¾ »ç¿ë)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Ambulatory Cardiac Monitoring Devices Market to Reach US$12.3 Billion by 2030

The global market for Ambulatory Cardiac Monitoring Devices estimated at US$6.8 Billion in the year 2024, is expected to reach US$12.3 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. ECG Devices, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$6.4 Billion by the end of the analysis period. Growth in the Holter Monitors segment is estimated at 10.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 14.1% CAGR

The Ambulatory Cardiac Monitoring Devices market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 14.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 9.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Ambulatory Cardiac Monitoring Devices Market - Key Trends & Drivers Summarized

Why Are Ambulatory Cardiac Monitoring Devices Essential in Modern Healthcare?

Ambulatory cardiac monitoring devices have become a cornerstone of modern cardiovascular healthcare, offering continuous and real-time monitoring of heart activity outside traditional clinical settings. These devices provide critical insights into arrhythmias, atrial fibrillation, and other heart conditions that may not be detectable during short-term clinical assessments. The increasing prevalence of cardiovascular diseases (CVDs), driven by sedentary lifestyles, rising obesity rates, and aging populations, has significantly fueled the demand for ambulatory monitoring solutions. Patients and healthcare providers are increasingly relying on these devices to detect irregular heart rhythms over extended periods, leading to timely diagnosis and intervention. Additionally, ambulatory cardiac monitoring devices facilitate long-term tracking of patients post-treatment, ensuring better management of chronic cardiac conditions and reducing the risk of recurrent cardiac events.

The shift towards home-based healthcare and the growing emphasis on preventive medicine have further bolstered the adoption of ambulatory cardiac monitoring devices. Patients prefer these devices due to their convenience, comfort, and ability to provide accurate data without the need for frequent hospital visits. Healthcare providers, on the other hand, leverage these devices to optimize patient management, reduce hospital readmissions, and allocate resources more efficiently. With the rising burden on healthcare systems globally, ambulatory cardiac monitoring is proving to be a valuable tool in reducing healthcare costs while improving patient outcomes. The integration of advanced technologies such as AI-driven analytics and real-time remote monitoring has further enhanced the usability and effectiveness of these devices, making them indispensable in contemporary healthcare settings.

How Are Technological Advancements Enhancing Ambulatory Cardiac Monitoring Devices?

Technological advancements are revolutionizing the field of ambulatory cardiac monitoring by enhancing the accuracy, portability, and functionality of these devices. The development of wearable devices equipped with advanced biosensors has enabled the continuous and non-invasive monitoring of vital cardiac parameters such as heart rate, rhythm, and electrical activity. Wireless connectivity features, including Bluetooth and cloud-based platforms, allow for seamless data transmission to healthcare providers, facilitating real-time monitoring and remote consultations. This connectivity not only improves patient compliance but also enables timely medical interventions in cases of abnormal cardiac events. Furthermore, the integration of artificial intelligence and machine learning algorithms into monitoring devices has significantly improved data interpretation, allowing for the early detection of cardiac anomalies with greater precision.

Miniaturization and ergonomic design have also played a crucial role in enhancing patient comfort and compliance with ambulatory cardiac monitoring. Traditional bulky Holter monitors are being replaced by lightweight and discreet wearable devices that allow patients to go about their daily activities without inconvenience. Devices such as event monitors and patch-based ECG monitors have gained traction, offering higher patient acceptance due to their ease of use and extended wear duration. Additionally, advancements in battery technology have enabled longer monitoring periods, reducing the need for frequent device replacements or recharging. The incorporation of smartphone applications that sync with these devices has further empowered patients to take control of their heart health by providing instant feedback and alerts, promoting proactive healthcare management.

What Are the Emerging Trends in the Ambulatory Cardiac Monitoring Devices Market?

Several emerging trends are shaping the future of the ambulatory cardiac monitoring devices market, driven by evolving patient expectations and technological innovations. One of the most significant trends is the growing demand for continuous remote monitoring solutions, particularly in the wake of the COVID-19 pandemic, which accelerated the adoption of telehealth services. Healthcare providers are increasingly deploying ambulatory cardiac monitors to track patients remotely, ensuring timely medical intervention without the need for in-person visits. This trend is particularly evident in the management of high-risk cardiac patients, where continuous monitoring is critical for preventing life-threatening events.

Another key trend is the rising adoption of wearable fitness devices with built-in cardiac monitoring capabilities, which are increasingly being used for early detection of heart irregularities. As consumer awareness of heart health continues to grow, wearable health technology is evolving to provide more advanced monitoring features, blurring the lines between medical-grade devices and consumer electronics. Furthermore, the expansion of cloud-based analytics platforms is enabling healthcare providers to access large-scale patient data, identify trends, and develop personalized treatment plans based on real-world insights. The focus on patient-centric care and precision medicine is driving the development of customizable monitoring solutions that cater to the specific needs of individual patients, offering tailored insights and recommendations.

What Are the Key Factors Driving the Growth of the Ambulatory Cardiac Monitoring Devices Market?

The growth in the ambulatory cardiac monitoring devices market is driven by several factors, including the rising incidence of cardiovascular diseases, advancements in wearable health technology, and increasing demand for remote patient monitoring solutions. The proliferation of IoT-enabled devices and AI-powered analytics is facilitating seamless data collection and interpretation, enhancing the efficiency of ambulatory monitoring. The shift in consumer behavior toward proactive healthcare management is driving the demand for user-friendly and non-invasive monitoring solutions that empower patients to take control of their heart health. Additionally, the growing preference for home-based care and outpatient monitoring is pushing healthcare providers to invest in cost-effective ambulatory cardiac monitoring solutions that reduce hospital admissions and improve patient outcomes. The increasing adoption of digital health platforms and telemedicine services is also contributing to market growth by enabling seamless integration of monitoring data with electronic health records (EHRs) for better clinical decision-making. Government initiatives and reimbursement policies aimed at promoting preventive healthcare and reducing healthcare costs are further encouraging the widespread adoption of ambulatory cardiac monitoring devices across healthcare systems worldwide.

SCOPE OF STUDY:

The report analyzes the Ambulatory Cardiac Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (ECG Devices, Holter Monitors, Event Monitors, Mobile Cardiac Telemetry Devices, Implantable Loop Recorders); End-Use (Hospitals and Clinics, Ambulatory Care Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â